iodine I 131 MIP-1095
Term · Oncology and biomedicine · MLC-T-ONC-014527
A radioconjugate composed of MIP-1095, a urea-based ligand for the tumor-associated antigen (TAA) prostate-specific membrane antigen (PSMA), radiolabeled with iodine I 131 (I131), with potential antineoplastic activity. Upon administration of iodine I 131 MIP-1095, the MIP-1095 moiety selectively targets and binds to the extracellular domain of PSMA, thereby delivering cytotoxic iodine I 131 specifically to PSMA-expressing cancer cells. PSMA is a transmembrane glycoprotein that is highly expressed by malignant prostate epithelial cells and certain other tumor cells.
| Identifier | MLC-T-ONC-014527 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 131I-MIP-1095; MIP-1095 I-131; I-131 MIP-1095; (131) I-MIP-1095 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014527",
"term": "iodine I 131 MIP-1095",
"field": "Oncology and biomedicine",
"definition": "A radioconjugate composed of MIP-1095, a urea-based ligand for the tumor-associated antigen (TAA) prostate-specific membrane antigen (PSMA), radiolabeled with iodine I 131 (I131), with potential antineoplastic activity. Upon administration of iodine I 131 MIP-1095, the MIP-1095 moiety selectively targets and binds to the extracellular domain of PSMA, thereby delivering cytotoxic iodine I 131 specifically to PSMA-expressing cancer cells. PSMA is a transmembrane glycoprotein that is highly expressed by malignant prostate epithelial cells and certain other tumor cells.",
"synonyms": [
"131I-MIP-1095",
"MIP-1095 I-131",
"I-131 MIP-1095",
"(131) I-MIP-1095"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/iodine-i-131-mip-1095/"
}
Record 9,508 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.